Scarica l'app Stockscreener
3.31
1.22%
0.04
Precedente Chiudi:
$3.27
Aprire:
$3.26
Volume 24 ore:
6,680
Relative Volume:
0.67
Capitalizzazione di mercato:
$4.93M
Reddito:
$27.40M
Utile/perdita netta:
$-17.12M
Rapporto P/E:
-0.031
EPS:
-106.8896
Flusso di cassa netto:
$-24.99M
1 W Prestazione:
-6.89%
1M Prestazione:
-4.34%
6M Prestazione:
+10.33%
1 anno Prestazione:
-77.27%
Intervallo 1D:
$3.26
$3.42
Intervallo di 1 settimana:
$3.10
$3.74
Portata 52W:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Nome
Dna X Inc
Settore
Industria
Telefono
650-378-8100
Indirizzo
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MS, GS, SCHW, HOOD, IBKR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.31 | 4.93M | 27.40M | -17.12M | -24.99M | -106.89 |
MS
Morgan Stanley
|
178.47 | 280.30B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
875.78 | 255.00B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
89.58 | 154.91B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
96.52 | 86.78B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
81.35 | 36.86B | 10.76B | 4.56B | 35.82B | 2.326 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-10-31 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Iniziato | B. Riley FBR | Buy |
| 2019-07-09 | Aggiornamento | National Securities | Neutral → Buy |
| 2019-06-10 | Iniziato | National Securities | Neutral |
| 2019-06-04 | Iniziato | Lake Street | Buy |
| 2019-06-04 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Dna X Inc Borsa (SONM) Ultime notizie
SONM 8-K & SEC Filings - Yahoo Finance Australia
SONM 8-K/A & SEC Filings - Yahoo Finance Australia
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
DNA X, Inc.: Dividend historical data and projections - www.marketscreener.com
DNAGinkgo Bioworks Holdings Inc. | News - OTC Markets
A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan
Applied DNA Sciences, Inc. (OTC: BNBX) Share Price, BNBX Stock News, BNBX Share Price & Updates - Kalkine
AIxCrypto Holdings, Inc. (AIXC) stock price, news, quote and history - Yahoo Finance UK
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - kalkine.ca
VEON Ltd. (VEON) stock price, news, quote and history - uk.finance.yahoo.com
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance Singapore
Ginkgo Bioworks (NYSE: DNA) director sells 5,000 shares near $7.08 - Stock Titan
Director plans potential 5,000-share sale at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Management Guidance Update - careplusvn.com
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
SONM 8-K & SEC Filings - Yahoo Finance Australia
Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan
Ginkgo Bioworks (DNA) officer to sell 330 shares for taxes after vesting - Stock Titan
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
DNA X: Q2 Earnings Snapshot - marketscreener.com
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X: Q2 Earnings Snapshot - KTVB
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
DNA X Inc: Expects Revenue From Trading Platf - Moomoo
DNA X, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - vinanet.vn
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
META_TITLE_QUOTE - Yahoo Finance
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
Dna X Inc Azioni (SONM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.51%
6.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):